Tema Oncology ETF (CANC) Short Interest Ratio & Short Volume

Short interest is the volume of Tema Oncology ETF shares that have been sold short but have not yet been closed out or covered. As of May 31st, investors have sold 7,500 shares of CANC short. 0.28% of Tema Oncology ETF's shares are currently sold short. Learn More on Tema Oncology ETF's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CANC shares currently have a short interest ratio of 1.0. Learn More on Tema Oncology ETF's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.28% of Tema Oncology ETF's floating shares are currently sold short.

Tema Oncology ETF saw a increase in short interest during the month of May. As of May 31st, there was short interest totaling 7,500 shares, an increase of 92.3% from the previous total of 3,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.28% of Tema Oncology ETF's shares are currently sold short. Here is how the short interest of companies compare to Tema Oncology ETF: Fidelity Disruptive Communications ETF (0.01%), Global X E-Commerce ETF (0.04%), Roundhill Daily 2X Long Magnificent Seven ETF (0.21%), Procure Space ETF (10.47%), Invesco ESG NASDAQ 100 ETF (1.50%), Spear Alpha ETF (0.65%), Global X Aging Population ETF (0.05%), AOT Growth & Innovation ETF (0.09%), Fidelity Disruptive Medicine ETF (0.03%), Tema Cardiovascular and Metabolics ETF (0.02%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks.

Short selling CANC is an investing strategy that aims to generate trading profit from Tema Oncology ETF as its price is falling. CANC shares are trading up $0.36 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Tema Oncology ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CANC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CANC, twice per month. The most recent reporting period available is May, 31 2025.